Impact of irritable bowel syndrome: Prevalence and effect on health-related quality of life

Reviews in Gastroenterological Disorders

Volumn 3, Issue SUPPL. 2, 2003, Pages

  El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Health related quality of life; Irritable bowel syndrome; SF 36

Indexed keywords

CLINICAL FEATURE; CONSTIPATION; CONSULTATION; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; IRRITABLE COLON; MALE; MEASUREMENT; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; UNITED STATES;

COLONIC DISEASES, FUNCTIONAL; HUMANS; PREVALENCE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 0038446614     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910-1915.
2. Hahn BA, Saunders WB, Maier WC. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci. 1997;42:2585-2590.
3. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
4. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927-934.
5. Chey WD, Olden K, Carter E, et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol. 2002;97:2803-2811.
6. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835-840.
7. Olden KW, Drossman DA. Psychological and psychiatric aspects of gastrointestinal disease. Med Clin North Am. 2000;84:1313-1327.
8. Guyatt GH, Feeny D, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
9. Ware JE Jr. The SF-36 Health Survey. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincot-Raven, 1996:337-345.
10. Rentz AM, Battista C, Trudeau E, et al. Symptom and health-related quality of life measures for selected gastrointestinal disease studies. Pharmacoeconomics. 2001;19:349-363.
11. El Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002;16:1171-1185.
12. Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci. 1996;41:2248-2253.
13. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995;50:184-189.
14. McGee HM, O'Boyle CA, Hickey A, et al. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med. 1991;21:749-759.
15. Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134:860-868.
16. Drossman DA, Patrick DL, Whitehead WE, et al. Further validations of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95:999-1007.
17. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654-660.
18. Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95:974-980.
19. Lee OY, Fitzgerald LZ, Naliboff B, et al. Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome. Aliment Pharmacol Ther. 1999;13:1631-1638.
20. Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999;94:2929-2935.
21. Hahn BA, Yan S, Strassel S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and the United Kingdom. Digestion. 1999;60:77-81.
22. Patrick DL, Drossman DA, Frederick IO, et al. Quality of life in persons with irritable bowel syndrome. Dig Dis Sci. 1998;43:400-411.
23. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553-559.
24. Akehurst RL, Brazier JE, Mathers N, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics. 2002;20:455-462.
25. Drossman DA, Zhiming LI, Leserman J, et al. Health status by gastrointestinal diagnosis and the abuse history. Gastroenterology. 1996;110:999-1007.
26. Frank L, Kleinman L, Rentz A, et al. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675-689.
27. Mathias JR, Clench MH, Abell TL, et al. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci. 1998;43:1347-1355.
28. Watson ME, Lacey L, Kong S, et al. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:455-459.
29. Heymann-Monnikes I, Arnold R, Florin I, et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981-994.
30. Chassany O, Bergmann JF. Quality of life in irritable bowel syndrome, effect of therapy. Eur J Surg Suppl. 1998;583:81-86.
31. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527-533.
32. Simrén M, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001;36:545-552.
33. Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol. 2001;96:2184-2193.
34. Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002;20:749-758.